Feb 3, 2005 by Brian GormanPolo's Off and RunningPolo Ralph Lauren's inventory management and retail expansion are showing results.
Feb 2, 2005 by Brian GormanDaimler's New InvestorDubai's investment in DaimlerChrysler appears to be about more than the automaker's long-term prospects.
Feb 2, 2005 by Brian GormanPfizer's Troubling Trust IssueThe company is in danger of losing the public's confidence.
Jan 31, 2005 by Brian GormanTribune Missing the Scoop on Growth?2004 didn't turn out as Tribune expected, but the company may be barking up the wrong tree as it seeks to bolster results.
Jan 27, 2005 by Brian GormanCovance's Higher PerformanceThe company's productivity gains and bundled service strategy are driving results.
Jan 26, 2005 by Brian GormanKraft's Problem AreaInternational operations have to be high on the company's list as it seeks to improve its performance.
Jan 25, 2005 by Brian GormanMonsanto Picks SeminisMonsanto's latest acquisition provides a sensible avenue for growth.
Jan 24, 2005 by Brian GormanMedicare on the BlockThe government may freeze Medicare reimbursements to long-term care providers.
Jan 21, 2005 by Brian GormanEU Goes After Junk FoodThe EU has threatened legislation on junk food advertising and labeling.
Jan 20, 2005 by Brian GormanAn Eye Toward ChangeViacom should be cautious in its plans to revamp CBS Evening News.
Jan 19, 2005 by Brian GormanDaimler Charges AheadEven if it becomes a niche car, the new Dodge Charger should be a success for DaimlerChrysler.
Jan 18, 2005 by Brian GormanCardinal Doesn't Get RuffledThe drug distributor's potential loss of a customer will hurt in the short term, but the company continues to plan wisely.
Dec 29, 2004 by Brian GormanRaptor Under AttackThe Pentagon is considering scaling back Lockheed Martin's Raptor program.
Dec 21, 2004 by Brian GormanBristol-Myers, Gilead Team UpThe drugmakers' alliance will benefit both the companies and HIV patients.
Dec 21, 2004 by Brian GormanPfizer Won't Let GoPfizer is hoping that Celebrex will survive in some form.
Dec 20, 2004 by Brian GormanCemex's BuildupThe cement and concrete giant is seeing strong growth from government housing projects.
Dec 20, 2004 by Brian GormanCambridge Antibody's Underdog StoryCambridge Antibody's legal success against Abbott Laboratories is a sign of the biotech industry's continued maturation.
Dec 17, 2004 by Brian GormanFedEx Is Flying HighThe company reported strong fiscal second-quarter results and positive trends seem likely to continue to drive healthy growth.
Dec 17, 2004 by Brian GormanYahoo! Goes for LaughsThe online giant signs a new content deal with JibJab.
